Dahowski Diane
Known title: EVP, Global Supply ChainCIK: 0001926636
Associated companies
Transaction History
| BIO | ▲ Buy | Option Exercise | 600 | $0 | 9/4/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 275 | $109K | 9/4/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 495 | $0 | 9/3/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 172 | $68K | 9/3/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 361 | $0 | 9/2/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 125 | $49K | 9/2/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 520 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 180 | $71K | 9/1/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 329 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 114 | $45K | 9/1/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 600 | $0 | 9/5/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 298 | $143K | 9/5/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 600 | $0 | 9/4/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 298 | $143K | 9/4/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 495 | $0 | 9/3/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 188 | $90K | 9/3/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 361 | $0 | 9/2/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 125 | $60K | 9/2/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 329 | $0 | 9/1/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 114 | $55K | 9/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth
The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth. The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.